Hydreight Technologies (TSXV: NURS) is a rapidly growing telehealth network that allows patients to book healthcare professionals to come to them. It's sometimes called the "Uber for Nurses" platform.
NURS has grown quarterly revenue from $1,695,134 in 4Q 2022, to $2,348,416 in 1Q 2023, to $2,699,668 in 2Q 2023, to $3,088,219 in 3Q 2023, to $3,373,193 in 4Q 2023, to $3,377,606 in 1Q 2024, to $4,100,212 in 2Q 2024, and to $4,526,320 in 3Q 2024!
You are going to be hearing a lot about Hydreight over the next year because NURS is building one of the largest mobile clinical networks across the United States.
NURS has its own proprietary, fully integrated platform comprising Electronic Medical Records, Telemedicine, and mobile booking and charting technology.
Hydreight's VSDHOne platform helps businesses launch direct-to-consumer healthcare brands!
NURS empowers nurses by giving them the ability to operate their own mobile wellness business with ease and without any of the traditional challenges of running their own business.
Currently, over 3,000 nurses and over 100 doctors are part of Hydreight’s 50-state network being established in the United States!
You may have heard of the popular weight loss drug Semaglutide? Well, you can get low-cost Semaglutide through Hydreight including a needle-free, sublingual version of Semaglutide!
On February 27th, NURS announced the expansion of its VSDHOne platform with a new suite of oral weight loss therapies in three convenient delivery formats: sublingual, capsule, and tablet. This expansion strengthens Hydreight’s leadership in telehealth innovation while positioning the company to participate in the booming global weight loss market!
New Weight Loss Treatments Include:
Three Flexible Delivery Formats Tailored for Convenience
Hydreight now offers patients greater flexibility with three convenient ways to take their medications:
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from NURS of US$30,000 cash for a three-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.